James Martin's Insider Trades & SAST Disclosures
James Martin's most recent trade in Janus Henderson Group plc was a trade of 19,924 Common Stock done at an average price of $41.7 . Disclosure was reported to the exchange on Feb. 28, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern James Martin.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Janus Henderson Group plc | Roger Martin James Thompson | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 41.71 per share. | 28 Feb 2025 | 19,924 | 150,727 (0%) | 0% | 41.7 | 831,030 | Common Stock |
| Janus Henderson Group plc | Roger Martin James Thompson | CHIEF FINANCIAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 41.74 per share. | 28 Feb 2025 | 6,980 | 143,747 (0%) | 0% | 41.7 | 291,354 | Common Stock |
| Janus Henderson Group plc | Roger Martin James Thompson | CHIEF FINANCIAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 41.61 per share. | 28 Feb 2025 | 3,360 | 140,387 (0%) | 0% | 41.6 | 139,807 | Common Stock |
| Cocrystal Pharma Inc | James Martin | Co-CEO and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Oct 2024 | 40,000 | 40,569 (0%) | 0% | - | Common Stock | |
| Janus Henderson Group plc | Roger Martin James Thompson | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 35.60 per share. | 11 Sep 2024 | 9,000 | 130,171 (0%) | 0% | 35.6 | 320,403 | Common Stock |
| Janus Henderson Group plc | Roger Martin James Thompson | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 35.38 per share. | 11 Sep 2024 | 9,000 | 139,171 (0%) | 0% | 35.4 | 318,453 | Common Stock |
| Janus Henderson Group plc | Roger Martin James Thompson | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 31.07 per share. | 01 Mar 2024 | 2,806 | 145,304 (0%) | 0% | 31.1 | 87,191 | Common Stock |
| Janus Henderson Group plc | Roger Martin James Thompson | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 30.93 per share. | 28 Feb 2024 | 30,656 | 126,439 (0%) | 0% | 30.9 | 948,270 | Common Stock |
| Janus Henderson Group plc | Roger Martin James Thompson | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 31.10 per share. | 28 Feb 2024 | 21,659 | 148,110 (0%) | 0% | 31.1 | 673,595 | Common Stock |
| PetVivo Holdings Inc | James Martin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Dec 2023 | 33,898 | 33,898 | - | - | Stock Option (right to buy) | |
| PetVivo Holdings Inc | James Martin | Director | Purchase of securities on an exchange or from another person at price $ 2.35 per share. | 21 Aug 2023 | 7,300 | 139,191 | - | 2.4 | 17,155 | Common Stock |
| PetVivo Holdings Inc | James Martin | Director | Purchase of securities on an exchange or from another person at price $ 2.21 per share. | 21 Aug 2023 | 4,482 | 146,041 | - | 2.2 | 9,905 | Common Stock |
| PetVivo Holdings Inc | James Martin | Director | Purchase of securities on an exchange or from another person at price $ 2.33 per share. | 21 Aug 2023 | 2,600 | 130,817 | - | 2.3 | 6,058 | Common Stock |
| PetVivo Holdings Inc | James Martin | Director | Purchase of securities on an exchange or from another person at price $ 2.28 per share. | 21 Aug 2023 | 2,100 | 127,217 | - | 2.3 | 4,788 | Common Stock |
| PetVivo Holdings Inc | James Martin | Director | Purchase of securities on an exchange or from another person at price $ 2.29 per share. | 21 Aug 2023 | 1,850 | 141,041 | - | 2.3 | 4,237 | Common Stock |
| PetVivo Holdings Inc | James Martin | Director | Purchase of securities on an exchange or from another person at price $ 2.34 per share. | 21 Aug 2023 | 1,300 | 125,117 | - | 2.3 | 3,042 | Common Stock |
| PetVivo Holdings Inc | James Martin | Director | Purchase of securities on an exchange or from another person at price $ 2.24 per share. | 21 Aug 2023 | 1,000 | 128,217 | - | 2.2 | 2,240 | Common Stock |
| PetVivo Holdings Inc | James Martin | Director | Purchase of securities on an exchange or from another person at price $ 2.27 per share. | 21 Aug 2023 | 850 | 131,891 | - | 2.3 | 1,930 | Common Stock |
| PetVivo Holdings Inc | James Martin | Director | Purchase of securities on an exchange or from another person at price $ 2.18 per share. | 21 Aug 2023 | 300 | 141,559 | - | 2.2 | 654 | Common Stock |
| PetVivo Holdings Inc | James Martin | Director | Purchase of securities on an exchange or from another person at price $ 2.20 per share. | 21 Aug 2023 | 218 | 141,259 | - | 2.2 | 480 | Common Stock |
| PetVivo Holdings Inc | James Martin | Director | Purchase of securities on an exchange or from another person at price $ 2.32 per share. | 21 Aug 2023 | 200 | 131,041 | - | 2.3 | 464 | Common Stock |
| PetVivo Holdings Inc | James Martin | Director | Purchase of securities on an exchange or from another person at price $ 2.17 per share. | 21 Aug 2023 | 24 | 130,841 | - | 2.2 | 52 | Common Stock |
| Cocrystal Pharma Inc | James Martin | Co-CEO and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jul 2023 | 30,000 | 30,000 | - | - | Stock Options (Right to Buy) | |
| Janus Henderson Group plc | Roger Martin James Thompson | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2023 | 25,560 | 164,928 (0%) | 0% | 0 | Common Stock | |
| Janus Henderson Group plc | Roger Martin James Thompson | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 27.37 per share. | 28 Feb 2023 | 6,327 | 155,666 (0%) | 0% | 27.4 | 173,153 | Common Stock |
| Janus Henderson Group plc | Roger Martin James Thompson | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 27.43 per share. | 28 Feb 2023 | 2,935 | 161,993 (0%) | 0% | 27.4 | 80,499 | Common Stock |
| PetVivo Holdings Inc | James Martin | Director | Purchase of securities on an exchange or from another person at price $ 3.00 per share. | 21 Feb 2023 | 2,500 | 125,419 | - | 3 | 7,500 | Common Stock |
| PetVivo Holdings Inc | James Martin | Director | Purchase of securities on an exchange or from another person at price $ 2.98 per share. | 21 Feb 2023 | 700 | 126,219 | - | 3.0 | 2,086 | Common Stock |
| PetVivo Holdings Inc | James Martin | Director | Purchase of securities on an exchange or from another person at price $ 2.99 per share. | 21 Feb 2023 | 100 | 125,519 | - | 3.0 | 299 | Common Stock |
| PetVivo Holdings Inc | James Martin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2023 | 1,610 | 18,910 | - | - | Warrants (right to buy) | |
| PetVivo Holdings Inc | James Martin | Director | Purchase of securities on an exchange or from another person at price $ 2.99 per share. | 16 Feb 2023 | 103 | 114,619 | - | 3.0 | 308 | Common Stock |
| PetVivo Holdings Inc | James Martin | Director | Purchase of securities on an exchange or from another person at price $ 2.64 per share. | 15 Feb 2023 | 7,900 | 122,416 | - | 2.6 | 20,856 | Common Stock |
| PetVivo Holdings Inc | James Martin | Director | Purchase of securities on an exchange or from another person at price $ 2.95 per share. | 15 Feb 2023 | 400 | 122,816 | - | 3.0 | 1,180 | Common Stock |
| PetVivo Holdings Inc | James Martin | Director | Purchase of securities on an exchange or from another person at price $ 2.55 per share. | 15 Feb 2023 | 100 | 114,516 | - | 2.6 | 255 | Common Stock |
| PetVivo Holdings Inc | James Martin | Director | Purchase of securities on an exchange or from another person at price $ 2.57 per share. | 14 Feb 2023 | 4,000 | 114,017 | - | 2.6 | 10,280 | Common Stock |
| PetVivo Holdings Inc | James Martin | Director | Purchase of securities on an exchange or from another person at price $ 2.54 per share. | 14 Feb 2023 | 3,500 | 110,017 | - | 2.5 | 8,890 | Common Stock |
| PetVivo Holdings Inc | James Martin | Director | Purchase of securities on an exchange or from another person at price $ 2.71 per share. | 14 Feb 2023 | 300 | 114,317 | - | 2.7 | 813 | Common Stock |
| PetVivo Holdings Inc | James Martin | Director | Purchase of securities on an exchange or from another person at price $ 2.56 per share. | 14 Feb 2023 | 99 | 114,416 | - | 2.6 | 253 | Common Stock |
| PetVivo Holdings Inc | James Martin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Oct 2022 | 25,424 | 25,424 | - | - | Stock Option (right to buy) | |
| PetVivo Holdings Inc | James Martin | Director | Purchase of securities on an exchange or from another person at price $ 2.45 per share. | 16 Aug 2022 | 2,500 | 97,584 | - | 2.5 | 6,125 | Common Stock |
| PetVivo Holdings Inc | James Martin | Director | Purchase of securities on an exchange or from another person at price $ 2.36 per share. | 16 Aug 2022 | 600 | 95,084 | - | 2.4 | 1,416 | Common Stock |
| PetVivo Holdings Inc | James Martin | Director | Purchase of securities on an exchange or from another person at price $ 2.47 per share. | 16 Aug 2022 | 578 | 98,184 | - | 2.5 | 1,428 | Common Stock |
| PetVivo Holdings Inc | James Martin | Director | Purchase of securities on an exchange or from another person at price $ 2.36 per share. | 16 Aug 2022 | 300 | 94,484 | - | 2.4 | 708 | Common Stock |
| PetVivo Holdings Inc | James Martin | Director | Purchase of securities on an exchange or from another person at price $ 2.36 per share. | 16 Aug 2022 | 22 | 97,606 | - | 2.4 | 52 | Common Stock |
| Cocrystal Pharma Inc | James Martin | Co- Interim CEO and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jul 2022 | 300,000 | 300,000 | - | - | Stock Options (Right to Buy) | |
| PetVivo Holdings Inc | James Martin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2022 | 6,740 | 6,740 | - | - | Employee Stock Option (right to buy) | |
| Janus Henderson Group plc | Roger Martin James Thompson | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 31.23 per share. | 02 Mar 2022 | 11,830 | 144,184 (0%) | 0% | 31.2 | 369,486 | Common Stock |
| Janus Henderson Group plc | Roger Martin James Thompson | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 31.78 per share. | 02 Mar 2022 | 4,055 | 138,531 (0%) | 0% | 31.8 | 128,864 | Common Stock |
| Janus Henderson Group plc | Roger Martin James Thompson | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 31.69 per share. | 02 Mar 2022 | 1,598 | 142,586 (0%) | 0% | 31.7 | 50,637 | Common Stock |
| Janus Henderson Group plc | Roger Martin James Thompson | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2022 | 69,269 | 156,014 (0%) | 0% | 0 | Common Stock | |
| PetVivo Holdings Inc | James Martin | Director | Purchase of securities on an exchange or from another person at price $ 1.52 per share. | 28 Feb 2022 | 7,500 | 94,184 | - | 1.5 | 11,393 | Common Stock |
| Janus Henderson Group plc | Roger Martin James Thompson | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 33.53 per share. | 28 Feb 2022 | 2,288 | 86,745 (0%) | 0% | 33.5 | 76,714 | Common Stock |
| PetVivo Holdings Inc | James Martin | Director | Purchase of securities on an exchange or from another person at price $ 2.45 per share. | 05 Oct 2021 | 600 | 86,684 | - | 2.5 | 1,470 | Common Stock |
| PetVivo Holdings Inc | James Martin | Director | Purchase of securities on an exchange or from another person at price $ 2.47 per share. | 05 Oct 2021 | 500 | 85,584 | - | 2.5 | 1,235 | Common Stock |
| PetVivo Holdings Inc | James Martin | Director | Purchase of securities on an exchange or from another person at price $ 2.46 per share. | 05 Oct 2021 | 500 | 86,084 | - | 2.5 | 1,232 | Common Stock |
| PetVivo Holdings Inc | James Martin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2021 | 8,333 | 93,417 | - | 0 | Common Stock | |
| PetVivo Holdings Inc | James Martin | Director | Purchase of securities on an exchange or from another person at price $ 2.96 per share. | 14 Sep 2021 | 1,200 | 85,084 | - | 3.0 | 3,552 | Common Stock |
| PetVivo Holdings Inc | James Martin | Director | Purchase of securities on an exchange or from another person at price $ 3.27 per share. | 13 Sep 2021 | 2,000 | 78,884 | - | 3.3 | 6,540 | Common Stock |
| PetVivo Holdings Inc | James Martin | Director | Purchase of securities on an exchange or from another person at price $ 3.25 per share. | 13 Sep 2021 | 2,000 | 80,884 | - | 3.3 | 6,500 | Common Stock |
| PetVivo Holdings Inc | James Martin | Director | Purchase of securities on an exchange or from another person at price $ 3.20 per share. | 13 Sep 2021 | 1,500 | 82,384 | - | 3.2 | 4,800 | Common Stock |
| PetVivo Holdings Inc | James Martin | Director | Purchase of securities on an exchange or from another person at price $ 3.24 per share. | 13 Sep 2021 | 1,000 | 83,884 | - | 3.2 | 3,240 | Common Stock |
| PetVivo Holdings Inc | James Martin | Director | Purchase of securities on an exchange or from another person at price $ 3.17 per share. | 13 Sep 2021 | 500 | 82,884 | - | 3.2 | 1,585 | Common Stock |
| PetVivo Holdings Inc | James Martin | Director | Purchase of securities on an exchange or from another person at price $ 2.70 per share. | 25 Aug 2021 | 1,300 | 76,184 | - | 2.7 | 3,510 | Common Stock |
| PetVivo Holdings Inc | James Martin | Director | Purchase of securities on an exchange or from another person at price $ 2.61 per share. | 25 Aug 2021 | 700 | 76,884 | - | 2.6 | 1,826 | Common Stock |
| PetVivo Holdings Inc | James Martin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Aug 2021 | 11,000 | 14,800 | - | - | Common Stock Warrant | |
| PetVivo Holdings Inc | James Martin | Director | Purchase of securities on an exchange or from another person at price $ 3.48 per share. | 11 Aug 2021 | 5,000 | 72,384 | - | 3.5 | 17,424 | Common Stock |
| PetVivo Holdings Inc | James Martin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Aug 2021 | 3,000 | 3,000 | - | - | Common Stock Warrant | |
| PetVivo Holdings Inc | James Martin | Director | Purchase of securities on an exchange or from another person at price $ 4.49 per share. | 11 Aug 2021 | 2,500 | 74,884 | - | 4.5 | 11,225 | Common Stock |
| PetVivo Holdings Inc | James Martin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Aug 2021 | 2,500 | 17 | - | - | Common Stock Warrant | |
| PetVivo Holdings Inc | James Martin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Aug 2021 | 800 | 3,800 | - | - | Common Stock Warrant | |
| Cocrystal Pharma Inc | James Martin | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jul 2021 | 250,000 | 250,000 | - | - | Stock Options (Right to Buy) | |
| Cocrystal Pharma Inc | James Martin | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2020 | 150,000 | 150,000 | - | - | Stock Options (Right to Buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges